A Prospective Study to Evaluate Revita DMR Post Market Pilot Clinical Follow-Up Registry in Patient With Type 2 Diabetes

NCT06256497 · clinicaltrials.gov ↗
SUSPENDED
Status
100
Enrollment
INDUSTRY
Sponsor class

Stopped The company paused enrollment due to a strategic decision to pause commercialization in the EU and specifically Germany. The company will follow currently enrolled subjects per protocol.

Conditions

Interventions

Sponsor

Fractyl Health Inc.